These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27104044)

  • 1. Preventive effect of ascorbic acid against biological function of human immunodeficiency virus trans-activator of transcription.
    Hayash T
    J Intercult Ethnopharmacol; 2016; 5(2):205-9. PubMed ID: 27104044
    [No Abstract]   [Full Text] [Related]  

  • 2. Transcriptional activation in vitro by the human immunodeficiency virus type 1 Tat protein: evidence for specific interaction with a coactivator(s).
    Song CZ; Loewenstein PM; Green M
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9357-61. PubMed ID: 7937769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multifunctional expression vector for an anti-HIV-1 ribozyme that produces a 5'- and 3'-trimmed trans-acting ribozyme, targeted against HIV-1 RNA, and cis-acting ribozymes that are designed to bind to and thereby sequester trans-activator proteins such as Tat and Rev.
    Yuyama N; Ohkawa J; Koguma T; Shirai M; Taira K
    Nucleic Acids Res; 1994 Nov; 22(23):5060-7. PubMed ID: 7800500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the tat and nef gene products of human immunodeficiency virus type 1 (HIV-1) on transcription controlled by the HIV-1 long terminal repeat and on cell growth in macrophages.
    Murphy KM; Sweet MJ; Ross IL; Hume DA
    J Virol; 1993 Dec; 67(12):6956-64. PubMed ID: 8230418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the human immunodeficiency virus Tat trans-activator contain a discrete activation domain?
    Tiley LS; Brown PH; Cullen BR
    Virology; 1990 Oct; 178(2):560-7. PubMed ID: 2219707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The carboxy-terminal transcription enhancement region of the human spumaretrovirus transactivator contains discrete determinants of the activator function.
    Venkatesh LK; Chinnadurai G
    J Virol; 1993 Jul; 67(7):3868-76. PubMed ID: 8389909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of vaccinia virus vectors to study the synthesis, intracellular localization, and action of the human immunodeficiency virus trans-activator protein.
    Falkner FG; Fuerst TR; Moss B
    Virology; 1988 Jun; 164(2):450-7. PubMed ID: 2835862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus type 2 (HIV-2) trans-activator (Tat): functional domains and the search for trans-dominant negative mutants.
    Arya SK
    AIDS Res Hum Retroviruses; 1993 Sep; 9(9):839-48. PubMed ID: 8257633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A trans-activator function is generated by integration of hepatitis B virus preS/S sequences in human hepatocellular carcinoma DNA.
    Caselmann WH; Meyer M; Kekulé AS; Lauer U; Hofschneider PH; Koshy R
    Proc Natl Acad Sci U S A; 1990 Apr; 87(8):2970-4. PubMed ID: 2158099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein.
    Kamine J; Subramanian T; Chinnadurai G
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8510-4. PubMed ID: 1924310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein.
    Green M; Loewenstein PM
    Cell; 1988 Dec; 55(6):1179-88. PubMed ID: 2849509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 Tat protein trans-activates transcription in vitro.
    Marciniak RA; Calnan BJ; Frankel AD; Sharp PA
    Cell; 1990 Nov; 63(4):791-802. PubMed ID: 2225077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of synthetic tat peptides in human immunodeficiency virus type 1 long terminal repeat-promoted transcription in a cell-free system.
    Jeyapaul J; Reddy MR; Khan SA
    Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7030-4. PubMed ID: 2205850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional trans activation by human immunodeficiency virus type 1 Tat requires specific coactivators that are not basal factors.
    Suñé C; García-Blanco MA
    J Virol; 1995 May; 69(5):3098-107. PubMed ID: 7707538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and characterization of the trans-activator of HTLV-III/LAV virus.
    Wright CM; Felber BK; Paskalis H; Pavlakis GN
    Science; 1986 Nov; 234(4779):988-92. PubMed ID: 3490693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 structural gene expression requires binding of the Rev trans-activator to its RNA target sequence.
    Malim MH; Tiley LS; McCarn DF; Rusche JR; Hauber J; Cullen BR
    Cell; 1990 Feb; 60(4):675-83. PubMed ID: 2406030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional analysis of the Tat trans activator of human immunodeficiency virus type 2.
    Fenrick R; Malim MH; Hauber J; Le SY; Maizel J; Cullen BR
    J Virol; 1989 Dec; 63(12):5006-12. PubMed ID: 2555537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteogenic effect of interleukin-11 and synergism with ascorbic acid in human periodontal ligament cells.
    Leon ER; Iwasaki K; Komaki M; Kojima T; Ishikawa I
    J Periodontal Res; 2007 Dec; 42(6):527-35. PubMed ID: 17956465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of specific amino acid residues in the acidic domain I of VSV phosphoprotein (P) converts a GAL4-P(I) hybrid into a transcriptional activator.
    Takacs AM; Perrine KG; Barik S; Banerjee AK
    New Biol; 1991 Jun; 3(6):581-91. PubMed ID: 1655011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural requirements for conserved Arg52 residue for interaction of the human immunodeficiency virus type 1 trans-activation responsive element with trans-activator of transcription protein (49-57). Capillary electrophoresis mobility shift assay.
    Mucha P; Szyk A; Rekowski P; Barciszewski J
    J Chromatogr A; 2002 Aug; 968(1-2):211-20. PubMed ID: 12236505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.